# Evaluation of the Severity of Hepatic Fibrosis by Magnetic Resonance Elastography in the Diagnosis of Endogenous Hypercorticism

> **NCT05911620** · NA · RECRUITING · sponsor: **Central Hospital, Nancy, France** · enrollment: 21 (estimated)

## Conditions studied

- Cushing Syndrome
- Metabolic Syndrome

## Interventions

- **DEVICE:** Magnetic resonance elastography (MRE)

## Key facts

- **NCT ID:** NCT05911620
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-24
- **Primary completion:** 2026-02-28
- **Final completion:** 2026-08-31
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2023-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05911620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05911620, "Evaluation of the Severity of Hepatic Fibrosis by Magnetic Resonance Elastography in the Diagnosis of Endogenous Hypercorticism". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05911620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
